NewSpring Ventures
[NewSpring Ventures](http://www.crunchbase.com/financial-organization/newspring-ventures) is the venture capital arm of [NewSpring Capital](http://www.crunchbase.com/financial-organization/newspring-capital). NewSpring Ventures is a venture fund that provides capital for growth, expansion, recapitalizations and venture buy-outs to businesses located in the Mid-Atlantic region of the United States. The fund invests in companies focused on enabling technology, business services, and information technology. The NewSpring Ventures investment team has a wealth of experience and expertise, with more than 60 combined years of experience in venture capital, investment banking, finance, accounting, and operations. In particular, the team values operating experience – since the investment professionals have themselves been CEOs and senior managers of companies in industries ranging from banking to transportation to the Internet, and have founded or co-founded seven companies. Each team member strives to add value to their portfolio companies and limited partners by professionalizing the investment process, fostering good corporate governance practices, strengthening operating experience, and leveraging professional networks. As investors, the NewSpring Ventures investment professionals have collectively raised six funds and managed nine funds. The team maintains active co-investment relationship with more than 50 venture fund families, diversified by geography, strategy, stage, and style. They also maintain a strong regional network for deal flow, management recruitment, banking relationships, and service providers. And they have invested in or advised more than 100 venture portfolio companies during the past 14 years with 32 positive liquidity events to date. NewSpring Ventures differentiates itself from other capital groups with its combination of deep operating and investing experience, proprietary deal flow, creative approach to deal structuring, prudent due diligence, and oversight process of investment.
NitroSecurity is a supplier of Unified Information Security solutions that provide Edge-to-Core network security for enterprises across many vertical markets, including healthcare, education, financial services, government, retail, hospitality, and managed services. Leveraging patented data management technology, NitroSecurity delivers an integrated, cost effective network security product suite for security information & event management, log management, database activity monitoring, network analysis and intrusion prevention.
NitroSecurity is a supplier of Unified Information Security solutions that provide Edge-to-Core network security for enterprises across many vertical markets, including healthcare, education, financial services, government, retail, hospitality, and managed services. Leveraging patented data management technology, NitroSecurity delivers an integrated, cost effective network security product suite for security information & event management, log management, database activity monitoring, network analysis and intrusion prevention.
Bluenog Corporation is an enterprise software and solutions provider based in Somerset, New Jersey, founded in 2006. The company specializes in developing software applications and integrations primarily utilizing Oracle technologies. Bluenog offers a range of services including content management, collaboration, business intelligence, and portal solutions, focusing on enhancing service-oriented architecture and information management. Its software facilitates seamless connections between third-party applications and Oracle systems, improving operational efficiency across various industries such as healthcare, finance, retail, and telecommunications. Additionally, Bluenog provides implementation and support services to ensure effective use of its solutions.
EKR Therapeutics, Inc. is a specialty pharmaceutical company based in Bedminster, New Jersey, established in 2005. The company is dedicated to acquiring, developing, and commercializing prescription products that primarily focus on oncology supportive care. EKR Therapeutics addresses various medical conditions, including oral mucositis, stomatitis, xerostomia, nutritional issues, cachexia, skin reactions, bone marrow depression, and pain management, among others. Their products are designed to support the needs of patients in acute-care hospital settings, particularly cancer patients, by providing effective treatments for complications related to cancer and other conditions.
Sopherion Therapeutics, LLC is a privately held biopharmaceutical company headquartered in Princeton, New Jersey with offices in Cheshire, Connecticut, Estero, Florida and an operating subsidiary, Sopherion Therapeutics Canada, in Toronto, Canada. Sopherion Therapeutics LLC is a specialty biopharmaceutical company with an exclusive licensing agreement with Zeneus Pharma Ltd., now Cephalon, Inc., for the commercialization of Myocet™ (a liposome-encapsulated doxorubicin-citrate complex) in the United States and Canada. Sopherion’s current business focus is the execution of a Phase III, global, randomized, registration trial for first line therapy of invasive, metastatic breast cancer and the development and commercialization of Sopherion’s lead agent, Myocet™. Myocet is being investigated in an FDA agreed upon registration trial in combination with two other drugs, Herceptin® (Trastuzumab) and Taxol (Paclitaxel) vs. Herceptin® and Taxol alone, the current standard of care for first line HER-2-overexpressing metastatic breast cancer. Myocet™, a liposome-encapsulated doxorubicin with reduced cardiotoxicity, is a nanotechnology product that localizes into tumor vasculature and in contrast to parental doxorubicin avoids homing to the heart. This 363 patient global trial in twelve countries has as of 03/06/09 been fully recruited. Unblinding is anticipated by the summer of 2010 with NDA submission for full approval following within 6 months. Myocet® is already a registered drug in Canada, where Sopherion has commercial rights and in Europe where Cephalon has commercial rights for use in first line metastatic breast cancer in combination with cyclophosphamide.; Their Phase III trial is based on a Phase II trial, supported by Roche, which gave a 96% response rate and two and a half year median progression free survival for patients with metastatic breast cancer.
Othera Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on treatments for ophthalmic diseases. Its products include OT-551 for geographic atrophy/dry age-related macular degeneration; OT-730 a small molecule oculoselective beta-blocker for reducing the elevated intraocular pressure associated with glaucoma; and OT-440, a neuroprotectant for glaucoma. The company was founded in 2002 and is headquartered in Exton, Pennsylvania.
CorrectNet is a leading provider of managed service-based information delivery and client reporting solutions tailored for the investment management sector. Established in 1997, the company specializes in the aggregation, enrichment, quality assurance, and formatting of complex investment data. It serves some of the largest investment management firms globally, offering tools such as the InfiPOINT platform for client reporting and Advisor WebTools for wealth advisors. CorrectNet is recognized for its capability to meet the stringent transparency and reporting requirements of hedge funds, funds of funds, fund administrators, and prime brokers, delivering comprehensive reporting through sophisticated web portals designed for investors, portfolio managers, operations teams, and executives.
Fiberlink Communications Corporation provides mobility as a service (MaaS) that helps enterprises to connect, control, and secure laptops and mobile devices. Its MaaS Platform helps mobile workers to connect to the Internet and the applications and data they need. The company's MaaS platform is used to perform identity management and authentication services; deploy, monitor, and manage security and connectivity applications on laptops and PCs; view information on compliance status, security events, and connectivity costs; and protect mobile devices and the data from loss, theft, data leakage, hackers, and viruses. Its MaaS360 mobility platform manages security and connectivity services on mobile and remote devices, as well as helps administrators to deploy, monitor, update, and remediate various endpoint security and connectivity applications.
CorrectNet is a leading provider of managed service-based information delivery and client reporting solutions tailored for the investment management sector. Established in 1997, the company specializes in the aggregation, enrichment, quality assurance, and formatting of complex investment data. It serves some of the largest investment management firms globally, offering tools such as the InfiPOINT platform for client reporting and Advisor WebTools for wealth advisors. CorrectNet is recognized for its capability to meet the stringent transparency and reporting requirements of hedge funds, funds of funds, fund administrators, and prime brokers, delivering comprehensive reporting through sophisticated web portals designed for investors, portfolio managers, operations teams, and executives.
Ripple Technologies provides data access and database monitoring solutions. The company offers RippleTech Informant, a database monitoring and security tool for monitoring and analysis of damaging data access trends. It also provides RippleTech LogCaster, a log and event management product that enables monitoring and recording of access to applications, as well as pre-defined report templates for auditing and compliance. The company serves financial, telecom, healthcare, technology, manufacturing, pharmaceutical, government, and universities. It has strategic partnerships with IBM, Microsoft, MySQL Enterprise, and Oracle. The company was founded in 1998 and is headquartered in Conshohocken, Pennsylvania. As of July 15, 2008, Ripple Technologies, Inc. operates as a subsidiary of NitroSecurity.
Step 9 Software offers web-enabled, pre-integrated operational support systems for communication providers.
iSun Networks is a social networking and software infrastructure company that caters to educational institutes. It produces software that enables colleges and universities to develop virtual communities. iSun Networks is a U.S.-based company that was founded in 2000 by Byron Guernsey.
Teaming with you, Omnient provides one-stop solutions for all of your e-business and e-commerce needs. They explore your vision and analyze your options, making sense of internet technology and mapping the best routes. They help you plan for growth... and the unexpected.
Fiberlink Communications Corporation provides mobility as a service (MaaS) that helps enterprises to connect, control, and secure laptops and mobile devices. Its MaaS Platform helps mobile workers to connect to the Internet and the applications and data they need. The company's MaaS platform is used to perform identity management and authentication services; deploy, monitor, and manage security and connectivity applications on laptops and PCs; view information on compliance status, security events, and connectivity costs; and protect mobile devices and the data from loss, theft, data leakage, hackers, and viruses. Its MaaS360 mobility platform manages security and connectivity services on mobile and remote devices, as well as helps administrators to deploy, monitor, update, and remediate various endpoint security and connectivity applications.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.